Levin Michael C, Lee Sangmin, Gardner Lidia A, Shin Yoojin, Douglas Joshua N, Cooper Chelsea
Veterans Administration Medical Center, Memphis, TN, USA ; Department of Neurology, University of Tennessee Health Science Center, Memphis, TN, USA ; Department of Neuroscience, University of Tennessee Health Science Center, Memphis, TN, USA.
Veterans Administration Medical Center, Memphis, TN, USA ; Department of Neurology, University of Tennessee Health Science Center, Memphis, TN, USA.
J Clin Cell Immunol. 2013 Jun 30;4. doi: 10.4172/2155-9899.1000148.
For years, investigators have sought to prove that myelin antigens are the primary targets of autoimmunity in multiple sclerosis (MS). Recent experiments have begun to challenge this assumption, particularly when studying the neurodegenerative phase of MS. T-lymphocyte responses to myelin antigens have been extensively studied, and are likely early contributors to the pathogenesis of MS. Antibodies to myelin antigens have a much more inconstant association with the pathogenesis of MS. Recent studies indicate that antibodies to non-myelin antigens such as neurofilaments, neurofascin, RNA binding proteins and potassium channels may contribute to the pathogenesis of MS. The purpose of this review is to analyze recent studies that examine the role that autoantibodies to non-myelin antigens might play in the pathogenesis of MS.
多年来,研究人员一直试图证明髓鞘抗原是多发性硬化症(MS)自身免疫的主要靶点。最近的实验开始对这一假设提出挑战,尤其是在研究MS的神经退行性阶段时。针对髓鞘抗原的T淋巴细胞反应已得到广泛研究,并且可能是MS发病机制的早期促成因素。针对髓鞘抗原的抗体与MS发病机制的关联则更为不稳定。最近的研究表明,针对神经丝、神经束蛋白、RNA结合蛋白和钾通道等非髓鞘抗原的抗体可能在MS发病机制中起作用。本综述的目的是分析最近的研究,这些研究探讨了针对非髓鞘抗原的自身抗体在MS发病机制中可能发挥的作用。